Literature DB >> 28388738

Riboflavin-Responsive Multiple Acyl-CoA Dehydrogenase Deficiency Associated with Hepatoencephalomyopathy and White Matter Signal Abnormalities on Brain MRI.

Päivi Vieira1, Päivi Myllynen2, Marja Perhomaa3, Hannu Tuominen4, Riikka Keski-Filppula5, Seppo Rytky6, Leila Risteli2, Johanna Uusimaa1,7.   

Abstract

Multiple acyl-CoA dehydrogenase deficiency (MADD) is a rare inborn error of metabolism affecting both fatty acid and amino acid oxidation. It can manifest at any age, but riboflavin-responsiveness has mainly been described in less severely affected patients. We describe an infant with severe MADD presenting with profound hypotonia and hepatomegaly. Treatment with riboflavin improved his muscle strength, liver size, and biochemical markers. A homozygous mutation of electron transfer flavoprotein dehydrogenase (ETFDH) was found. His motor skills continued to progress until a fatal infection-triggered deterioration at the age of 34 months. We show changes in brain magnetic resonance imaging over the course of the disease, with profound white matter abnormalities during the deterioration phase. Aggregates of mitochondria with abnormal cristae in muscle electron microscopy were noticed already in infancy. An unusual lactate dehydrogenase (LDH) isoenzyme pattern with LDH-1 predominance was additionally observed. This case demonstrates riboflavin-responsiveness in a severely affected infant with both muscular and extramuscular involvement and further underlines the variable nature of this disease. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28388738     DOI: 10.1055/s-0037-1601447

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  5 in total

1.  [Multiple acyl-CoA dehydrogenase deficiency/glutaric aciduria type 2: difficult diagnosis, easy to treat].

Authors:  M Rabenstein; J Weis; A Abicht; G R Fink; H C Lehmann; G Wunderlich
Journal:  Nervenarzt       Date:  2020-04       Impact factor: 1.214

2.  Targeted Therapies for Metabolic Myopathies Related to Glycogen Storage and Lipid Metabolism: a Systematic Review and Steps Towards a 'Treatabolome'.

Authors:  A Manta; S Spendiff; H Lochmüller; R Thompson
Journal:  J Neuromuscul Dis       Date:  2021

3.  Late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (MADD): case reports and epidemiology of ETFDH gene mutations.

Authors:  Wei Chen; Youqiao Zhang; Yifeng Ni; Shaoyu Cai; Xin Zheng; Frank L Mastaglia; Jingshan Wu
Journal:  BMC Neurol       Date:  2019-12-18       Impact factor: 2.474

4.  A novel electron transfer flavoprotein dehydrogenase (ETFDH) gene mutation identified in a newborn with glutaric acidemia type II: a case report of a Chinese family.

Authors:  Mingcai Ou; Lin Zhu; Yong Zhang; Yaguo Zhang; Jingyao Zhou; Yu Zhang; Xuelian Chen; Lijuan Yang; Ting Li; Xingyue Su; Qi Hu; Wenjun Wang
Journal:  BMC Med Genet       Date:  2020-05-11       Impact factor: 2.103

Review 5.  Neonatal-onset multiple acyl-CoA dehydrogenase deficiency (MADD) in the ETFDH gene: A case report and a literature review.

Authors:  Meijuan Ding; Ruihua Liu; Li Qiubo; Yanke Zhang; Qingxia Kong
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.